GC-MS Profiling and Antineoplastic Activity of Pelargonium Inquinans Ait Leaves on Acute Leukaemia Cell Lines U937 and Jurkat

2021 ◽  
pp. 1-23
Author(s):  
Ogochukwu Izuegbuna ◽  
Gloria A. Otunola ◽  
Graeme Bradley
Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 4436-4436
Author(s):  
Stefania Grimaudo ◽  
Antonietta Di Cristina ◽  
Vincenzo Abbadessa ◽  
Simoni Daniele ◽  
Marinella Roberti ◽  
...  

Abstract The stilbene scaffold is a basic element for a number of biologically active natural and synthetic compounds and in accordance with Evans’ definition it can be considered as a privileged structure. One of the most relevant and studied stilbenes is Resveratrol, a phytoalexin present in grapes, endowed with chemopreventive and chemotherapeutic properties and able to induce apoptosis in different cancer cell lines. Since reduced apoptosis has been implicated in the development and progression of malignant tumors and in the occurrence of chemoresistant phenotypes, resveratrol-induced apoptosis might therefore contribute to its antitumor activity. However, resveratrol is a not potent cytotoxic compound if compared with others chemotherapeutic drugs and it is scarcely active in P-glycoprotein expressing (MDR) and Bcr-Abl expressing leukaemia cells. With the aim to find new stilbene compounds active in resistant leukaemia cells we synthesized a small library of resveratrol analogs, bearing the 3,5-dimethoxy motif at the A phenyl ring and amino, methoxy and hydroxy moieties at the 3′-and/or 4′-positions. Moreover, we synthesized analogues which incorporate a phenyl ring as bioisosteric substitution of the alkenyl bridge. Among these new stilbenes we identified two compounds endowed with interesting antileukemic properties: a) a methoxylated cis derivative active at nanomolar concentrations in P-glycoprotein expressing HL60-R and CEM VBL100 acute leukaemia cell lines and in P-glycoprotein and Bcr-Abl expressing K562-ADR cell line which is resistant to apoptosis induced by most common anticancer agents, and b) a terphenyl derivative active in MDR and Bcr-Abl expressing cell lines. Both compounds induced apoptosis prevalently through the mitochondrial pathway. Differently from resveratrol and other stilbenes, the therphenyl derivative induced a block of cells in G0-G1 phase of cell cycle which was associated to the shift of the phosphorylation state of pRb from hyperphosphorylated to hypophosphorylated. Morover, low concentrations of this compound were able to induced a potent granulocytic and monocytic differentiation of HL60 cells.


2009 ◽  
Vol 29 (4) ◽  
pp. 211-216 ◽  
Author(s):  
Jie Yao ◽  
Qing Huang ◽  
Xiao-Bing Zhang ◽  
Wei-Ling Fu

Previous studies have suggested an important role of ERs (oestrogen receptors) in the pathogenesis of leukaemias. However, there is no information so far about the epigenetic characteristics of ERα isoforms and ERβ in leukaemias. In the present study, the mRNA expression and promoter CpG methylation of ERα isoforms (i.e. ERα-A, -B and -C) and ERβ in leukaemia cell lines were evaluated using RT–PCR (reverse transcription–PCR) and MSP (methylation-specific PCR) respectively. The methylation of ERs was further analysed in acute leukaemia patients by MSP and direct DNA sequencing. Although all ERα isoforms and ERβ were methylated in all leukaemia cell lines, except for ERα-C, which was unmethylated in HL-60 and K562 cell lines, only the expression of ERα-A was deficient in all cell lines and its expression could be reactivated by DNA demethylation reagents. With regard to the methylation characteristics in acute leukaemia patients, only ERα-A was inactivated and specifically methylated (95%; 38/40) in almost all patients and unmethylated in all healthy controls, whereas ERα-B, -C and ERβ were methylated in both patients and healthy controls. This result suggested that the methylated status of ERα-A might serve as an epigenetic biomarker of leukaemias. The present study is the first report that demonstrates selective inactivation of ERα isoforms through the promoter CpG methylation pathway in leukaemias.


2014 ◽  
Vol 7 (5) ◽  
pp. 1651-1656 ◽  
Author(s):  
AXEL LUVIANO ◽  
ITZEN AGUIÑIGA-SÁNCHEZ ◽  
PATRICIA DEMARE ◽  
REYNALDO TIBURCIO ◽  
EDGAR LEDESMA-MARTÍNEZ ◽  
...  

2012 ◽  
Vol 53 ◽  
pp. S158-S159
Author(s):  
F. Vieceli Dalla Sega⁎ ◽  
L. Zambonin ◽  
D. Fiorentini ◽  
B. Rizzo ◽  
L. Landi ◽  
...  

2005 ◽  
Author(s):  
M. Stubbs ◽  
K. Khan ◽  
R. Wickremasinghe ◽  
K. Ganeshaguru ◽  
M. Caplin

Sign in / Sign up

Export Citation Format

Share Document